HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshinori Murakami Selected Research

Cell Adhesion Molecules

1/2020CADM1 suppresses c-Src activation by binding with Cbp on membrane lipid rafts and intervenes colon carcinogenesis.
1/2015Dynamic regulation of a cell adhesion protein complex including CADM1 by combinatorial analysis of FRAP with exponential curve-fitting.
1/2013Cell adhesion molecule 1 is a new osteoblastic cell adhesion molecule and a diagnostic marker for osteosarcoma.
6/2012Expression of a splicing variant of the CADM1 specific to small cell lung cancer.
3/2012Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma.
1/2012Tumor suppressor cell adhesion molecule 1 (CADM1) is cleaved by a disintegrin and metalloprotease 10 (ADAM10) and subsequently cleaved by γ-secretase complex.
2/2008[Involvement of a cell adhesion molecule, CADM1/TSLC1 in oncogenesis and spermatogenesis].
5/2006Disruption of spermatogenic cell adhesion and male infertility in mice lacking TSLC1/IGSF4, an immunoglobulin superfamily cell adhesion molecule.
12/2005Tumor suppressor in lung cancer (TSLC)1 suppresses epithelial cell scattering and tubulogenesis.
9/2005Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshinori Murakami Research Topics

Disease

48Neoplasms (Cancer)
12/2022 - 07/2002
11Lung Neoplasms (Lung Cancer)
09/2015 - 07/2002
7Adenocarcinoma of Lung
06/2020 - 04/2005
5Adenocarcinoma
06/2020 - 02/2012
4Neoplasm Metastasis (Metastasis)
10/2021 - 05/2010
4Hypoxia (Hypoxemia)
10/2021 - 03/2016
4Breast Neoplasms (Breast Cancer)
11/2019 - 06/2009
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2014 - 09/2002
3Carcinogenesis
01/2020 - 09/2005
3Infections
11/2016 - 04/2014
3Carcinoma (Carcinomatosis)
10/2016 - 03/2012
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
05/2022 - 02/2005
2Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 01/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 01/2020
2Adenocarcinoma in Situ
06/2020 - 07/2014
2Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2019
2Mouth Neoplasms (Oral Cancer)
01/2018 - 10/2016
2Pulmonary Emphysema
01/2018 - 03/2014
2Emphysema
01/2018 - 03/2014
2Neuroblastoma
05/2011 - 11/2008
2Meningioma (Meningiomas)
02/2006 - 10/2004
1Oropharyngeal Neoplasms
12/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2022
1Papillary Thyroid Cancer
12/2021
1Heart Diseases (Heart Disease)
12/2021
1Shock
10/2021
1Inguinal Hernia (Direct Inguinal Hernia)
08/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2019
1Genomic Instability
11/2019
1Arthritis (Polyarthritis)
01/2019
1Gout
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2019
1Urolithiasis
01/2019
1Triple Negative Breast Neoplasms
01/2019
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1Neoplasm Micrometastasis
01/2017

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
12/2020 - 09/2002
13Immunoglobulins (Immunoglobulin)IBA
01/2020 - 07/2002
12Cell Adhesion MoleculesIBA
01/2020 - 11/2003
10Cell Adhesion Molecule-1IBA
05/2022 - 10/2004
7DNA (Deoxyribonucleic Acid)IBA
12/2022 - 11/2008
5Biomarkers (Surrogate Marker)IBA
12/2022 - 10/2016
4Microfilament Proteins (Actin Binding Proteins)IBA
01/2015 - 04/2005
3Cadherins (E-Cadherin)IBA
11/2014 - 02/2013
3Membrane Glycoproteins (Membrane Glycoprotein)IBA
11/2003 - 07/2002
2Circulating Tumor DNAIBA
12/2022 - 12/2021
2Biological ProductsIBA
12/2021 - 01/2020
2LipidsIBA
12/2021 - 01/2019
2CytokinesIBA
10/2021 - 11/2016
2Oxygen (Dioxygen)IBA
10/2021 - 03/2016
2Estrogen ReceptorsIBA
01/2021 - 10/2011
2AgarIBA
06/2020 - 01/2016
2Transcription Factors (Transcription Factor)IBA
01/2020 - 02/2012
2Gefitinib (Iressa)FDA Link
01/2019 - 06/2009
2Uric Acid (Urate)IBA
01/2019 - 01/2019
2Epithelial Cell Adhesion MoleculeIBA
01/2018 - 03/2014
2SmokeIBA
01/2018 - 04/2006
2class-I restricted T cell-associated moleculeIBA
01/2016 - 04/2014
2Guanylate KinasesIBA
05/2010 - 09/2005
2hydrogen sulfite (bisulfite)IBA
10/2003 - 08/2002
1Cell-Free Nucleic AcidsIBA
12/2022
1Pharmaceutical PreparationsIBA
12/2021
1LDL CholesterolIBA
12/2021
1Formaldehyde (Formol)FDA Link
12/2021
1ParaffinIBA
12/2021
1naphthofluoresceinIBA
10/2021
1ElastinIBA
08/2021
1HLA-B*52:01 antigenIBA
10/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2020
1Colloids (Colloid)IBA
06/2020
1Trefoil Factor-1IBA
06/2020
1Exosome Multienzyme Ribonuclease ComplexIBA
01/2020
1Membrane LipidsIBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2020
1UbiquitinIBA
01/2020
1Ligases (Synthetase)IBA
01/2020
1Amino AcidsFDA Link
11/2019
1Dopamine Receptors (Dopamine Receptor)IBA
11/2019
1Phosphotransferases (Kinase)IBA
07/2019
1ErbB Receptors (EGF Receptor)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1CalciumIBA
01/2019
1ElectrolytesIBA
01/2019
1Carcinoembryonic AntigenIBA
10/2018
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
10/2018
1human ERBB2 proteinIBA
10/2018
1Nuclear Proteins (Protein, Nuclear)IBA
01/2018
1Keratins (Keratin)IBA
01/2018
11,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2017

Therapy/Procedure

6Therapeutics
11/2019 - 06/2009
1Aftercare (After-Treatment)
12/2022
1Genomic Medicine
02/2022
1Molecular Targeted Therapy
06/2020
1Drug Therapy (Chemotherapy)
01/2019
1Combination Drug Therapy (Combination Chemotherapy)
01/2019
1Radiotherapy
01/2017